BrainEver is a biotechnology company, with a focus on discovering and developing First-in-class therapies for the treatment of neurodegenerative diseases.
BrainEver innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and contr...
BrainEver is a biotechnology company, with a focus on discovering and developing First-in-class therapies for the treatment of neurodegenerative diseases.
BrainEver innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and control several neuronal functions, including epigenetic stability and metabolism. BrainEver makes the hypothesis that, in patients, homeoprotein administration could durably modify the physiological resistance.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.